The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for Exploratory Centers for Interdisciplinary Research in Benign Urology (P20). A major goal of this program is to build interdisciplinary research teams. The program seeks innovative, high-risk–high-reward Research Projects that utilize integrative approaches to address questions relevant to benign genitourinary diseases or disorders bringing together investigators with complementary expertise. Studies involving human subjects or tissues and small, innovative, pilot and feasibility clinical studies are encouraged. The following expertise must be included in the proposed Research Project: 1) researchers new to the investigation of benign genitourinary diseases or disorders and 2) clinical urology expertise. Additional expertise may also be included, as needed. In addition to the scientific Research Project, each Exploratory Center must include an Administrative Core with an Educational Enrichment Program. As part of the NIDDK's efforts to expand and enhance benign urology research and the base of urologic researchers, the Exploratory Centers Program will work in partnership with the George M. O'Brien Urology Cooperative Research Centers Program (U54) and the Multidisciplinary K12 Urologic Research (KURe and UroEpi) Career Development Programs.
- Letter of Intent Due Date: March 1, 2020
- Application Due Date(s): March 31, 2020
RFA-DK-19-033 Expiration Date: April 1, 2020
The Center Director should be an investigator with an established record of external funding but is not required to have a record of accomplishment in benign genitourinary research. Investigators who are key personnel of an existing U54 O'Brien Urology Center RFA-DK-16-013; RFA-DK-18-029; or an existing P20 Center in response to RFA-DK-18-028 are not eligible to apply as Center Director. An investigator, including Center Director, may only be listed as key personnel on only one P20 application in response to this RFA.
The maximum project period is 2 years. The scope of the proposed project should determine the project period.